Cai Lay Veterinary Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000MKV4
VND
26,400.00
2400 (10.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Cai Lay Veterinary Pharmaceutical JSC
SPM Corp. (Vietnam)
Mediplantex National Pharmaceutical JSC
OPC Pharmaceutical JSC
Domesco Medical Import-Export JSC
Binh Dinh Pharmaceutical & Medical Equipment JSC
F.I.T. Investment JSC
Ben Tre Pharmaceutical JSC
Ha Tay Pharmaceutical JSC
Cuu Long Pharmaceutical JSC
Mekophar Chemical Pharmaceutical JSC

Why is Cai Lay Veterinary Pharmaceutical JSC ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Cai Lay Veterinary Pharmaceutical JSC should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.13%
EBIT Growth (5y)
12.12%
EBIT to Interest (avg)
70.52
Debt to EBITDA (avg)
0.36
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
1.34
Tax Ratio
20.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.78%
ROE (avg)
9.28%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.54
EV to EBIT
2.64
EV to EBITDA
1.92
EV to Capital Employed
0.41
EV to Sales
0.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.51%
ROE (Latest)
6.93%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

34What is working for the Company
ROCE(HY)

Highest at 17.68%

OPERATING PROFIT(Q)

Highest at VND 10,458.11 MM

OPERATING PROFIT MARGIN(Q)

Highest at 26.5 %

PRE-TAX PROFIT(Q)

Highest at VND 8,731.26 MM

NET PROFIT(Q)

Highest at VND 6,984.42 MM

RAW MATERIAL COST(Y)

Fallen by -16.95% (YoY

CASH AND EQV(HY)

Highest at VND 68,314.55 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 4.03 times

NET SALES(Q)

At VND 39,470.39 MM has Grown at 15.17%

-15What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at 0 %

INTEREST(Q)

Highest at VND 1,049.43 MM

EPS(Q)

Lowest at VND 0

Here's what is working for Cai Lay Veterinary Pharmaceutical JSC

Pre-Tax Profit
At VND 8,731.26 MM has Grown at 173.88%
over average net sales of the previous four periods of VND 3,188.01 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (VND MM)

Operating Profit
Highest at VND 10,458.11 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (VND MM)

Operating Profit Margin
Highest at 26.5 % and Grown
In each period in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at VND 8,731.26 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (VND MM)

Net Profit
Highest at VND 6,984.42 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (VND MM)

Net Profit
At VND 6,984.42 MM has Grown at 174.7%
over average net sales of the previous four periods of VND 2,542.57 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (VND MM)

Net Sales
At VND 39,470.39 MM has Grown at 15.17%
over average net sales of the previous four periods of VND 34,271.59 MM
MOJO Watch
Near term sales trend is positive

Net Sales (VND MM)

Cash and Eqv
Highest at VND 68,314.55 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio
Highest at 4.03 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -16.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Cai Lay Veterinary Pharmaceutical JSC

Interest
At VND 1,049.43 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

Interest
Highest at VND 1,049.43 MM
in the last five periods and Increased by inf% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

EPS
Lowest at VND 0
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (VND)

Debt-Equity Ratio
Highest at 0 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio